Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells 35,000 Shares of Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00. Following the transaction, the director now owns 35,609 shares of the company’s stock, valued at approximately $2,349,837.91. This represents a 49.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Nicholas Dominic Cortezi also recently made the following trade(s):

• On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96.
• On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The stock was sold at an average price of $65.00, for a total value of $5,915.00.
• On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00.
• On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total transaction of $2,334,850.00.
• On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00.

Ryan Specialty Trading Down 0.2 %

RYAN stock opened at $66.20 on Thursday. Ryan Specialty Holdings, Inc. has a 52 week low of $42.21 and a 52 week high of $75.97. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company’s 50-day simple moving average is $68.19 and its 200 day simple moving average is $65.80. The company has a market capitalization of $17.33 billion, a PE ratio of 85.97, a price-to-earnings-growth ratio of 1.12 and a beta of 0.72.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. During the same quarter in the prior year, the business posted $0.32 EPS. The business’s revenue was up 20.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current year.

Ryan Specialty Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were issued a $0.11 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.66%. Ryan Specialty’s dividend payout ratio is presently 57.14%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $65.00 to $75.00 in a report on Tuesday, September 24th. Keefe, Bruyette & Woods decreased their target price on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Friday, January 10th. Barclays raised their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, November 21st. The Goldman Sachs Group upped their price objective on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a report on Wednesday, October 9th. Finally, Wells Fargo & Company cut their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and a consensus price target of $74.40.

Institutional Trading of Ryan Specialty

Several large investors have recently modified their holdings of the stock. Bar Harbor Wealth Management raised its stake in Ryan Specialty by 5.9% in the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock valued at $10,835,000 after purchasing an additional 9,482 shares in the last quarter. Cooper Financial Group increased its holdings in Ryan Specialty by 9.9% in the 4th quarter. Cooper Financial Group now owns 3,808 shares of the company’s stock valued at $244,000 after buying an additional 342 shares during the period. GAMMA Investing LLC raised its position in shares of Ryan Specialty by 38.1% in the 4th quarter. GAMMA Investing LLC now owns 1,725 shares of the company’s stock valued at $111,000 after buying an additional 476 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Ryan Specialty by 107.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after acquiring an additional 238,064 shares during the period. Finally, Principal Financial Group Inc. lifted its holdings in shares of Ryan Specialty by 148.9% during the 3rd quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock worth $56,545,000 after acquiring an additional 509,548 shares during the period. 84.82% of the stock is owned by institutional investors and hedge funds.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.